BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11834951)

  • 1. Post-exposure prophylaxis after non-occupational HIV exposure: impact of recommendations on physicians' experiences and attitudes.
    Laporte A; Jourdan N; Bouvet E; Lamontagne F; Pillonel J; Desenclos JC
    AIDS; 2002 Feb; 16(3):397-405. PubMed ID: 11834951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
    Merchant RC; Keshavarz R
    Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-exposure prophylaxis for non-occupational exposure to HIV: current clinical practice and opinions in the UK.
    Giele CM; Maw R; Carne CA; Evans BG;
    Sex Transm Infect; 2002 Apr; 78(2):130-2. PubMed ID: 12081175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry.
    Wang SA; Panlilio AL; Doi PA; White AD; Stek M; Saah A
    Infect Control Hosp Epidemiol; 2000 Dec; 21(12):780-5. PubMed ID: 11140914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To prescribe, or not to prescribe: decision making in HIV-1 post-exposure prophylaxis.
    Scholten M; Suárez I; Platten M; Kümmerle T; Jung N; Wyen C; Ernst A; Horn C; Burst V; Suárez V; Rybniker J; Fätkenheuer G; Lehmann C
    HIV Med; 2018 Oct; 19(9):645-653. PubMed ID: 29993176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed recommendations for the management of HIV post-exposure prophylaxis after sexual, injecting drug or other exposures in Europe.
    Almeda J; Casabona J; Simon B; Gerard M; Rey D; Puro V; Thomas T;
    Euro Surveill; 2004 Jun; 9(6):35-40. PubMed ID: 15223890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Post-exposure prophylaxis of HIV infection in out-patient clinic of hospital for infectious diseases in Warsaw in 2001-2002].
    Kowalska JD; Firlag-Burkacka E; Niezabitowska M; Bakowska E; Ignatowska A; Pulik P; Horban A
    Przegl Epidemiol; 2006; 60(4):789-94. PubMed ID: 17682761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior.
    Martin JN; Roland ME; Neilands TB; Krone MR; Bamberger JD; Kohn RP; Chesney MA; Franses K; Kahn JO; Coates TJ; Katz MH
    AIDS; 2004 Mar; 18(5):787-92. PubMed ID: 15075514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Danish PEP Registry: Experience with the use of post-exposure prophylaxis following blood exposure to HIV from 1999-2012.
    Lunding S; Katzenstein TL; Kronborg G; Storgaard M; Pedersen C; Mørn B; Lindberg JÅ; Kronborg TM; Jensen J
    Infect Dis (Lond); 2016; 48(3):195-200. PubMed ID: 26529586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of Postexposure Prophylaxis for HIV-1 in the Emergency Room: Correct Transmission Risk Assessment Remains Challenging.
    Marzel A; Heinrich H; Schilliger L; Fehr JS; Günthard HF; Kouyos R; Rampini SK
    J Acquir Immune Defic Syndr; 2017 Apr; 74(4):359-366. PubMed ID: 27906766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis against possible human immunodeficiency virus exposure after nonoccupational needlestick injuries or sexual assaults in children and adolescents.
    Babl FE; Cooper ER; Kastner B; Kharasch S
    Arch Pediatr Adolesc Med; 2001 Jun; 155(6):680-2. PubMed ID: 11386957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
    U.S. Public Health Service
    MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High risk for occupational exposure to HIV and utilization of post-exposure prophylaxis in a teaching hospital in Pune, India.
    Gupta A; Anand S; Sastry J; Krisagar A; Basavaraj A; Bhat SM; Gupte N; Bollinger RC; Kakrani AL
    BMC Infect Dis; 2008 Oct; 8():142. PubMed ID: 18939992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of knowledge, attitudes and practices of HIV post exposure prophylaxis among the doctors and nurses in Princess Marina Hospital, Gaborone: a cross-sectional study.
    Bareki P; Tenego T
    Pan Afr Med J; 2018; 30():233. PubMed ID: 30574252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in HIV postexposure prophylaxis prescription and compliance after sexual exposure in Amsterdam, 2000-2004.
    Sonder GJ; van den Hoek A; Regez RM; Brinkman K; Prins JM; Mulder JW; Veenstra J; Claessen FA; Coutinho RA
    Sex Transm Dis; 2007 May; 34(5):288-93. PubMed ID: 16980918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HIV post exposure prophylaxis therapy - the experience of two major AIDS centers].
    Elbirt D; Levy I; Asher I; Mahlev-Guri K; Rosenberg-Bezalet S; Litachevsky S; Radian-Sade S; Sthoeger Z
    Harefuah; 2013 Apr; 152(4):224-9, 246. PubMed ID: 23844525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of adverse events associated with antiretroviral regimens for postexposure prophylaxis for occupational and nonoccupational exposures to prevent transmission of human immunodeficiency virus.
    Luque A; Hulse S; Wang D; Shahzad U; Tanzman E; Antenozzi S; Smith B
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):695-701. PubMed ID: 17520543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects and tolerability of post-exposure prophylaxis with zidovudine, lamivudine, and lopinavir/ritonavir: a comparative study with HIV/AIDS patients.
    Cai J; Xiao J; Zhang Q
    Chin Med J (Engl); 2014; 127(14):2632-6. PubMed ID: 25043080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of HIV-postexposure prophylaxis prescription quality after a training programme and assistance in decisions provided by a computer-based decision program: a cross-over study.
    Casalino E; Bouzid D; Antoniol S; Choquet C; Colosi L; Pereira L; Agbessi A; Kenway P; Yazdanpanah Y; Ghazali DA
    Acta Clin Belg; 2022 Jun; 77(3):495-509. PubMed ID: 33783339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.